Products
Below is a list of the treatments we currently offer via our Innovative Medicines Division.
Please note: Not all treatments are available in all countries.
Showing 79 results
Kisqali*
(ribociclib)Protein Kinase InhibitorMore informationPlus d'informationKymriah*
(Tisagenlecleucel)Antineoplastic and immunomodulating agentsMore informationPlus d'informationLamisil
(terbinafine hydrochloride)More informationPlus d'informationLeqvio*
(Inclisiran)Interfering Ribonucleic Acid Proprotein convertase subtilisin kexin type 9 inhibitorMore informationPlus d'informationLocametz*
(Gallium (68Ga) Gozetotide)Diagnostic Radiopharmaceutical KitMore informationPlus d'informationLucentis*
(ranibizumab injection)Antineovascularisation agentMore informationPlus d'informationLutathera*
(Lutetium (177Lu) Oxodotreotide)Antineovascularisation agentMore informationPlus d'informationLuxturna*
(voretigene neparvovec)Recombinant adeno-associated virus 2 vector-based gene therapy ATC S01XA27More informationPlus d'informationMaxidex*
(dexamethasone)CorticosteroidMore informationPlus d'informationMaxitrol*
(neomycin, polymyxin B sulfates and dexamethasone)Anti-inflammatory/AntibioticMore informationPlus d'information